ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 109 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,120 | -11.7% | 4,000 | 0.0% | 0.00% | – |
| Q2 2023 | $9,200 | -24.1% | 4,000 | 0.0% | 0.00% | – |
| Q1 2023 | $12,120 | +30.0% | 4,000 | 0.0% | 0.00% | – |
| Q4 2022 | $9,320 | -6.8% | 4,000 | -20.0% | 0.00% | – |
| Q3 2022 | $10,000 | -28.6% | 5,000 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | -33.3% | 5,000 | -28.6% | 0.00% | – |
| Q1 2022 | $21,000 | -22.2% | 7,000 | 0.0% | 0.00% | – |
| Q4 2021 | $27,000 | -10.0% | 7,000 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $30,000 | +42.9% | 7,000 | 0.0% | 0.00% | – |
| Q2 2021 | $21,000 | -100.0% | 7,000 | -50.0% | 0.00% | – |
| Q1 2021 | $46,620,000 | +186380.0% | 14,000 | +100.0% | 0.00% | -100.0% |
| Q4 2020 | $25,000 | – | 7,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COWEN AND COMPANY, LLC | 4,331,020 | $7,882,000 | 1.31% |
| RTW INVESTMENTS, LP | 6,869,281 | $12,502,000 | 0.35% |
| A.R.T. Advisors, LLC | 14,140 | $26,000 | 0.04% |
| Hudson Bay Capital Management LP | 975,000 | $1,774,000 | 0.03% |
| Secure Asset Management, LLC | 10,000 | $18,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,774,935 | $3,230,000 | 0.01% |
| FNY Investment Advisers, LLC | 9,900 | $18,000 | 0.01% |
| Squarepoint Ops LLC | 322,225 | $586,000 | 0.01% |
| LMR Partners LLP | 107,912 | $196,000 | 0.01% |
| Virtu Financial LLC | 17,147 | $31,000 | 0.00% |